By Sarah N. Lynch
WASHINGTON, Sept 30 (Reuters) - GlaxoSmithKline willpay $20 million to settle civil charges that it masked improperbribes to foreign officials in China on its books by disguisingthem as legitimate travel, entertainment and marketing expenses,U.S. regulators said Friday.
The pharmaceutical company agreed to settle the case withthe Securities and Exchange Commission without admitting ordenying the charges. (Reporting by Sarah N. Lynch; editing by Diane Craft)